These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8167604)

  • 1. Guidelines for control of meningococcal disease. Bureau of Communicable Disease Epidemiology, Laboratory Centre for Disease Control, Ottawa, Ontario, Canada.
    Can Commun Dis Rep; 1994 Feb; 20(3):17-27. PubMed ID: 8167604
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal disease in Ontario during the winter of 1988-1989.
    Heimann GA; Mikel DE; Naus M; Goel V; Tischler M; Carlson JA; Schabas R; Pasut G; Borczyk A; Krishnan C
    Can Dis Wkly Rep; 1989 Mar; 15(11):59-62. PubMed ID: 2713946
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of meningococcal disease: guidance for consultants in communicable disease control. PHLS Meningococcal Infections Working Group and Public Health Medicine Environmental Group.
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R189-95. PubMed ID: 8556102
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for control of meningococcal disease. The Advisory Committee on Epidemiology.
    Can Dis Wkly Rep; 1991 Nov; 17(45):245-50. PubMed ID: 1843653
    [No Abstract]   [Full Text] [Related]  

  • 7. [Invasive meningococcal infections in the Fribourg canton. Reasons for and development of a vaccination program in Gruyere in February 2001].
    Renevey F; Demierre G; Chuard C; Regamey C
    Rev Med Suisse Romande; 2001 Aug; 121(8):569-72. PubMed ID: 11565217
    [No Abstract]   [Full Text] [Related]  

  • 8. Meningococcal vaccines: a neglected topic in travel medicine?
    Wilder-Smith A
    Expert Rev Vaccines; 2009 Oct; 8(10):1343-50. PubMed ID: 19803757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease: was Ottawa's mass-vaccination program necessary?
    Gray C
    CMAJ; 1992 Mar; 146(6):1033, 1036-7. PubMed ID: 1544060
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass voluntary immunization campaigns for meningococcal disease in Canada: media hysteria.
    Hume SE
    JAMA; 1992 Apr; 267(13):1833-4, 1837-8. PubMed ID: 1545470
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for controlling meningococcal disease.
    CMAJ; 1992 Mar; 146(6):939-42, 945-8. PubMed ID: 1544081
    [No Abstract]   [Full Text] [Related]  

  • 13. [Were the meningococcal vaccination campaigns in 1974-76 of benefit?].
    Peltola H; Nors T; Salminen S; Käyhty H; Sivonen A; Jousimies-Somer H; Mäkelä P
    Duodecim; 1983; 99(5):332-41. PubMed ID: 6872895
    [No Abstract]   [Full Text] [Related]  

  • 14. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology and prevention of meningococcal infection abroad].
    Chaĭka NA
    Tr Inst Im Pastera; 1983; 61():164-79. PubMed ID: 6379993
    [No Abstract]   [Full Text] [Related]  

  • 16. MeNZB vaccine and epidemic control: when do you stop vaccinating?
    Loring BJ; Turner N; Petousis-Harris H
    Vaccine; 2008 Nov; 26(47):5899-904. PubMed ID: 18804134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
    Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of measles experience in Ottawa, Ontario and Hull, Quebec.
    Can Dis Wkly Rep; 1990 Jun; 16(24):111-3. PubMed ID: 2397525
    [No Abstract]   [Full Text] [Related]  

  • 19. New guidelines for management and prevention of meningococcal disease in Australia. Meningococcal Disease Working Party of the National Health and Medical Research Council.
    Patel MS; Collignon PJ; Watson CR; Condon RJ; Doherty RR; Merianos A; Stewart GJ
    Med J Aust; 1997 Jun; 166(11):598-601. PubMed ID: 9201182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.